IL94693A0 - Dibenzo(1,5)dioxocin-5-one derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

Dibenzo(1,5)dioxocin-5-one derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL94693A0
IL94693A0 IL94693A IL9469390A IL94693A0 IL 94693 A0 IL94693 A0 IL 94693A0 IL 94693 A IL94693 A IL 94693A IL 9469390 A IL9469390 A IL 9469390A IL 94693 A0 IL94693 A0 IL 94693A0
Authority
IL
Israel
Prior art keywords
dioxocin
dibenzo
preparation
derivatives
pharmaceutical compositions
Prior art date
Application number
IL94693A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL94693A0 publication Critical patent/IL94693A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/12—Eight-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/80—Penicillium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
IL94693A 1989-06-13 1990-06-11 Dibenzo(1,5)dioxocin-5-one derivatives,their preparation and pharmaceutical compositions containing them IL94693A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3919255A DE3919255A1 (de) 1989-06-13 1989-06-13 Dibenzo/1,5/dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
IL94693A0 true IL94693A0 (en) 1991-04-15

Family

ID=6382649

Family Applications (1)

Application Number Title Priority Date Filing Date
IL94693A IL94693A0 (en) 1989-06-13 1990-06-11 Dibenzo(1,5)dioxocin-5-one derivatives,their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US5089487A (fr)
EP (1) EP0411268B1 (fr)
JP (1) JPH0324073A (fr)
KR (1) KR910000698A (fr)
CN (1) CN1048041A (fr)
AT (1) ATE121396T1 (fr)
AU (1) AU632578B2 (fr)
CA (1) CA2018659A1 (fr)
DD (1) DD298423A5 (fr)
DE (2) DE3919255A1 (fr)
DK (1) DK0411268T3 (fr)
ES (1) ES2072332T3 (fr)
FI (1) FI902901A0 (fr)
HU (2) HUT54136A (fr)
IE (1) IE902114A1 (fr)
IL (1) IL94693A0 (fr)
NO (1) NO175745C (fr)
NZ (1) NZ233989A (fr)
PT (1) PT94338A (fr)
ZA (1) ZA904524B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039860A1 (de) * 1990-12-13 1992-06-17 Bayer Ag Substituierte dibenz-oxa-thiocinone verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5198463A (en) * 1992-03-30 1993-03-30 Merck & Co., Inc. Oxytocin antagonists
JPH05280682A (ja) * 1992-04-01 1993-10-26 Kazuo Yano 屈曲自在なプラグイン・ワンタッチ接続型管継手装置
KR20010049586A (ko) * 1999-11-24 2001-06-15 윤종용 흡입마취용 식도내기관튜브
DE10250710A1 (de) * 2002-10-31 2004-05-19 Bayer Ag Neue Verwendung von Dioxocin-5-on-Derivaten
DE10250687A1 (de) * 2002-10-31 2004-05-13 Bayer Ag 7H-Dibenzo(b,g)(1,5)dioxocin-5-on-Derivate und ihre Verwendung
CN103044383B (zh) * 2011-10-17 2015-01-07 复旦大学 一种制备天然产物Penicillide消旋体的方法
CN103087040B (zh) * 2011-11-01 2015-10-28 复旦大学 Penicillide衍生物、其制备方法及其在药用用途
CN104370849A (zh) * 2014-11-13 2015-02-25 中科院广州化学有限公司 一种n-芳基二苯并氧氮杂环辛酮类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639612A (en) * 1969-05-16 1972-02-01 Lilly Co Eli Chalcogen containing heterocyclics as an in vitro anti-viral agent
US4751238A (en) * 1983-03-10 1988-06-14 Hoechst-Roussel Pharmaceuticals, Inc. Substituted alkyl amine derivatives of 6,11-dihydro-11-oxodibenz[b,e]oxepins
FR2580280B1 (fr) * 1985-04-11 1987-05-22 Synthelabo Derives d'acide dibenzo(be)oxepinne-acetique, leur preparation et leur application en therapeutique
JPH0560831B1 (fr) * 1986-06-17 1993-09-03 Dainippon Pharmaceutical Co
US4940726A (en) * 1989-04-26 1990-07-10 Arizona Board Of Regents Cell growth inhibitory macrocyclic lactones denominated Combretastatin D-1 and Combretastatin D-2
WO1991000009A1 (fr) * 1989-06-29 1991-01-10 Fermenta Asc Corporation Nouveaux glyoxylates et leur action herbicide et regulatrice de la croissance des vegetaux

Also Published As

Publication number Publication date
HU211554A9 (en) 1995-12-28
PT94338A (pt) 1991-02-08
DK0411268T3 (da) 1995-08-14
NO902400L (no) 1990-12-14
NO902400D0 (no) 1990-05-30
EP0411268A3 (en) 1991-07-03
HUT54136A (en) 1991-01-28
NO175745C (no) 1994-11-30
FI902901A0 (fi) 1990-06-11
ZA904524B (en) 1991-04-24
CA2018659A1 (fr) 1990-12-13
DE59008921D1 (de) 1995-05-24
DD298423A5 (de) 1992-02-20
EP0411268B1 (fr) 1995-04-19
CN1048041A (zh) 1990-12-26
ATE121396T1 (de) 1995-05-15
HU903811D0 (en) 1990-11-28
US5089487A (en) 1992-02-18
NO175745B (no) 1994-08-22
AU5600890A (en) 1990-12-20
KR910000698A (ko) 1991-01-30
JPH0324073A (ja) 1991-02-01
IE902114A1 (en) 1991-01-02
AU632578B2 (en) 1993-01-07
IE902114L (en) 1990-12-13
DE3919255A1 (de) 1990-12-20
ES2072332T3 (es) 1995-07-16
EP0411268A2 (fr) 1991-02-06
NZ233989A (en) 1993-03-26

Similar Documents

Publication Publication Date Title
NZ229787A (en) Amino ether diphosphonic acid derivatives and pharmaceutical compositions
IL103126A (en) 5-amino-4-hydroxyhexanoic acid derivatives, process for their preparation and pharmaceutical compositions containing them
IL84944A (en) Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation
GR3029406T3 (en) Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them.
IL94819A0 (en) 11beta-aryl-4-estrene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL98756A0 (en) Pharmaceutical compositions containing benzeneacetamid derivatives,certain such novel compounds and their preparation
IL78691A (en) Quinolylglycinamide derivatives,their preparation and pharmaceutical compositions containing them
IL94693A0 (en) Dibenzo(1,5)dioxocin-5-one derivatives,their preparation and pharmaceutical compositions containing them
ZA879280B (en) Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds
HU900746D0 (en) Process for preparation of 2,3,23-trihydroxy-urz-12-en and it's derivatives and for pharmaceutical compositions containing that compounds
DE3369983D1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use
AP9300581A0 (en) Benzofuran derivatives processes for their preparation and pharmaceutical compositions containing them and their medical use
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
IE873212L (en) Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor
PL286188A1 (en) Method of obtaining renine retarding aminooligohydroxy derivatives
ZA941196B (en) Angiopeptin cyclopeptide compounds process for the preparation thereof and pharmaceutical compositions containing them
IL100393A0 (en) 15-nitro-2beta,3beta-dihydro-and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives,their preparation and pharmaceutical compositions containing them
ES2049186A1 (es) Procedimiento para la preparacion de nuevos derivados de benzofuranil-imidazol.
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
IL104444A0 (en) Alpha-aryl-alpha-hydroxy-beta-imidazolinyl-propionamides,their preparation and pharmaceutical compositions containing them
HUT61776A (en) Process for producing 3' and/or 4' oh-modificated elsamycin derivatives and pharmaceutical compositions containing them as active components
IL83171A (en) 1,3,5-trithiane derivatives,process for preparation thereof and medical compositions containing them
IL97402A0 (en) 5-phenyl-1h-pyrazol-4-propionic acid derivatives,their preparation and pharmaceutical compositions containing them
HUT52111A (en) Process for producing cytidine-5'-diphosphatealkanols and -glycerine derivatives, as well pharmaceutical compositions comprising such compounds as active ingredient
EP0480458A3 (en) Process for the preparation of pharmaceutical compositions containing viminol useful in the treatment of drug dependences